Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CPEB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BICDL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ECSCR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIEXF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM86A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SECISBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DYRK1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTR4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASAH2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SORBS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADRB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C10orf25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF620 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505786 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CHMP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GALNT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP290 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on